We evaluated the implementation of a cystic fibrosis annual review process in a tertiary paediatric hospital. After implementation, there was demonstrated improvement in an important outcome measure-the use of inhaled mucolytic agents.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/archdischild-2017-313455 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!